HIV-Specific CD8+ T-Cells and Their Antiviral Efficacy
Author Information
Author(s): Ranasinghe Srinika R. F., Kramer Holger B., Wright Cynthia, Kessler Benedikt M., di Gleria Katalin, Zhang Yonghong, Gillespie Geraldine M., Blais Marie-Eve, Culshaw Abigail, Pichulik Tica, Simmons Alison, Rowland-Jones Sarah L., McMichael Andrew J., Dong Tao
Primary Institution: Medical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford
Hypothesis
The antiviral efficacy of HIV-specific CD8+ T-cells is dependent on the infecting HIV-1 isolate.
Conclusion
Only 23% of HIV-1 isolates with a conserved epitope were effectively recognized by CD8+ T-cells, indicating that viral diversity significantly impacts T-cell recognition and antiviral efficacy.
Supporting Evidence
- Only 23% of Nef proteins from HIV-1 isolates were optimally recognized by CTL.
- Viral isolate-specific polymorphisms in the epitope flanking region significantly altered CTL recognition.
- CTL antiviral efficacy was heavily dependent on the infecting HIV-1 isolate.
Takeaway
This study found that even if a part of the virus is the same, the body's immune cells might not recognize it if the virus has changed in other ways.
Methodology
The study used Viral Suppression Assays and Live Virus ELISPOTS to evaluate CTL recognition and antiviral efficacy against various HIV-1 isolates.
Limitations
The study primarily focused on in vitro assays, which may not fully represent in vivo conditions.
Participant Demographics
The study involved HIV-1 infected patients with diverse viral isolates.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website